Vivakor
VIVK
#10278
Rank
C$17.62 M
Marketcap
C$0.11
Share price
-12.22%
Change (1 day)
-94.65%
Change (1 year)

Revenue for Vivakor (VIVK)

Revenue in 2025 (TTM): C$0.17 Billion

According to Vivakor's latest financial reports the company's current revenue (TTM ) is C$0.17 Billion. In 2024 the company made a revenue of C$0.12 Billion an increase over the revenue in the year 2023 that were of C$78.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vivakor from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$0.17 B35.54%
2024 C$0.12 B63.8%
2023 C$78.68 M106.3%
2022 C$38.14 M2649.56%
2021 C$1.38 M
2009 C$0.11 M-50.57%
2008 C$0.23 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C$4.26 B 2,384.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.13 B-23.97%๐Ÿ‡บ๐Ÿ‡ธ USA